Pekka Taimen

Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells (2023)

International Journal of Molecular Sciences

Metsälä Olli, Wahlström Gudrun, Taimen Pekka, Kellokumpu-Lehtinen Pirkko-Liisa, Schleutker Johanna

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource (2022)

Cancer Epidemiology, Biomarkers and Prevention

Ouellet V., Erickson Andrew on behalf of GAP1 UTMAs Contributing Investigators, Wiley K., Morrissey C., Berge V., Moreno C.S., Tasken K.A., Trudel D., True L.D., Lewis M.S., Svindland A., Ertunc O., Vidal I.D., Osunkoya A.O., Jones T., Steven Bova G., Lamminen Tarja, Achtman A.H., Buzza M., Kouspou M.M., Bigler S.A., Zhou X., Freedland S.J., Mes-Masson A.M., Garraway I.P., Trock B.J., Taimen Pekka, Saad F., Mirtti T., Knudsen B.S., De Marzo A.M.

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis (2022)

Neoplasia

Talvitie Eva-Maria, Liljeroos Lassi, Vilhonen Heikki, Orte Katri, Leivo Ilmo, Kallajoki Markku, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers (2022)

Molecular Oncology

Aakula Anna, Isomursu Aleksi, Rupp Christian, Erickson Andrew, Gupta Nikhil, Kauko Otto, Shah Pragya, Padzik Artur, Pokharel Yuba Raj, Kaur Amanpreet, Li Song-Ping, Trotman Lloyd, Taimen Pekka, Rannikko Antti, Lammerding Jan, Paatero Ilkka, Mirtti Tuomas, Ivaska Johanna, Westermarck Jukka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)

Cancers

Yu Lan, Toriseva Mervi, Afshan Syeda, Cangiano Mario, Fey Vidal, Erickson Andrew, Seikkula Heikki, Alanen Kalle, Taimen Pekka, Ettala Otto, Nurmi Martti, Boström Peter J, Kallajoki Markku, Tuomela Johanna, Mirtti Tuomas, Beumer Inès J, Nees Matthias, Härkönen Pirkko

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

European Radiology

Beheshti Mohsen, Taimen Pekka, Kemppainen Jukka, Jambor Ivan, Mueller Andre, Loidl Wolfgang, Kähkönen Esa, Käkelä Meeri, Berndt Mathias, Stephens Andrew W., Minn Heikki, Langsteger Werner

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

Frontiers in Oncology

Anttinen Mikael, Sequeiros Roberto Blanco, Boström Peter J, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

BMJ Open

Ettala Otto, Jambor Ivan, Perez Ileana Montoya, Seppänen Marjo, Kaipia Antti, Seikkula Heikki, Syvänen Kari T, Taimen Pekka, Verho Janne, Steiner Aida, Saunavaara Jani, Saukko Ekaterina, Löyttyniemi Eliisa, Sjoberg Daniel D, Vickers Andrew, Aronen Hannu, Boström Peter

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

Frontiers in cell and developmental biology

West Gun, Turunen Minttu, Aalto Anna, Virtanen Laura, Li Song-Ping, Heliö Tiina, Meinander Annika, Taimen Pekka

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)

Human Molecular Genetics

Wahlström Gudrun, Heron Samuel, Knuuttila Matias, Kaikkonen Elina, Tulonen Nea, Metsälä Olli, Lof Christoffer, Ettala Otto, Boström Peter J., Taimen Pekka, Poutanen Matti, Schleutker Johanna

(Vertaisarvioitu alkuperäisartikkeli tai data-artikkeli tieteellisessä aikakauslehdessä (A1))

Contact

Links

Julkaisut

Järjestä:

Transcripts of the Prostate Cancer-Associated Gene ANO7 Are Retained in the Nuclei of Prostatic Epithelial Cells (2023)

The Movember Global Action Plan 1 (GAP1): Unique Prostate Cancer Tissue Microarray Resource (2022)

Comprehensive genomic profiling of Finnish lung adenocarcinoma cohort reveals high clinical actionability and SMARCA4 altered tumors with variable histology and poor prognosis (2022)

PP2A methylesterase PME-1 suppresses anoikis and is associated with therapy relapse of PTEN-deficient prostate cancers (2022)

Increased Expression and Altered Cellular Localization of Fibroblast Growth Factor Receptor-Like 1 (FGFRL1) Are Associated with Prostate Cancer Progression (2022)

Value of 68Ga-labeled bombesin antagonist (RM2) in the detection of primary prostate cancer comparing with [18F]fluoromethylcholine PET-CT and multiparametric MRI—a phase I/II study (2022)

Evolving imaging methods of prostate cancer and the emergence of magnetic resonance imaging guided ablation techniques (2022)

Individualised non-contrast MRI-based risk estimation and shared decision-making in men with a suspicion of prostate cancer: protocol for multicentre randomised controlled trial (multi-IMPROD V.2.0) (2022)

A heterozygous p.S143P mutation in LMNA associates with proteasome dysfunction and enhanced autophagy-mediated degradation of mutant lamins A and C (2022)

The variant rs77559646 associated with aggressive prostate cancer disrupts ANO7 mRNA splicing and protein expression (2022)